Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 14 Apr 2022

Prognostic Value of Heterogeneity Index Derived from Baseline 18F-FDG PET/CT in Mantle Cell Lymphoma

in Hematologic Malignancies

Fei Liu
Bingxin Gu
Nan Li
Herong Pan
Wen Chen
Ying Qiao
Shaoli Song
Xiaosheng Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.862473

3,351 views
6 citations

Original Research

Published on 14 Apr 2022

A Deep Learning Model for the Automatic Recognition of Aplastic Anemia, Myelodysplastic Syndromes, and Acute Myeloid Leukemia Based on Bone Marrow Smear

in Hematologic Malignancies

Meifang Wang
Chunxia Dong
Yan Gao
Jianlan Li
Mengru Han
Lijun Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.844978

5,485 views
36 citations

Review

Published on 14 Apr 2022

Chronic Neutrophilic Leukemia: A Comprehensive Review of Clinical Characteristics, Genetic Landscape and Management

in Hematologic Malignancies

Thomas P. Thomopoulos
Argiris Symeonidis
Alexandra Kourakli
Sotirios G. Papageorgiou
Vasiliki Pappa

Frontiers in Oncology

doi 10.3389/fonc.2022.891961

29,463 views
20 citations

Case Report

Published on 13 Apr 2022

Case Report: Castleman Disease With an Associated Stromal Spindle Cell Proliferation, PDGFRB Mutation and p53 Expression: Clonal Origins of a Rare Disease

in Hematologic Malignancies

Kunwar I. Singh
Sumanth Gollapudi
Jyoti Kumar
Alexandra Butzmann
Corinn Small
Sara Kreimer
Emine Arzu Saglam
Roger Warnke
Oscar Silva
Robert S. Ohgami

Frontiers in Oncology

doi 10.3389/fonc.2022.857606

3,791 views
4 citations

Brief Research Report

Published on 12 Apr 2022

Clonal Hematopoiesis at the Crossroads of Inflammatory Bowel Diseases and Hematological Malignancies: A Biological Link?

in Hematologic Malignancies

Cosimo Cumbo
Francesco Tarantini
Antonella Zagaria
Luisa Anelli
Crescenzio Francesco Minervini
Nicoletta Coccaro
Giuseppina Tota
Luciana Impera
Elisa Parciante
Maria Rosa Conserva

Frontiers in Oncology

doi 10.3389/fonc.2022.873896

4,443 views
21 citations

Original Research

Published on 12 Apr 2022

Diffuse Large B-Cell Lymphoma Promotes Endothelial-to-Mesenchymal Transition via WNT10A/Beta-Catenin/Snail Signaling

in Hematologic Malignancies

Xianting Sun
Jianchen Fang
Fen Ye
Shuxian Zhang
Honghui Huang
Jian Hou
Ting Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.871788

5,281 views
15 citations

Review

Published on 12 Apr 2022

Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis

in Hematologic Malignancies

Luca Guarnera
Tiziana Ottone
Emiliano Fabiani
Mariadomenica Divona
Arianna Savi
Serena Travaglini
Giulia Falconi
Paola Panetta
Maria Cristina Rapanotti
Maria Teresa Voso

Frontiers in Oncology

doi 10.3389/fonc.2022.871590

15,846 views
37 citations

Original Research

Published on 08 Apr 2022

Leukemia Stem Cell Frequency at Diagnosis Correlates With Measurable/Minimal Residual Disease and Impacts Survival in Adult Acute Myeloid Leukemia

in Hematologic Malignancies

Azza M. Kamel
Nahla M. Elsharkawy
Eman Z. Kandeel
Marwa Hanafi
Mohammed Samra
Randa A. Osman

Frontiers in Oncology

doi 10.3389/fonc.2022.867684

5,592 views
8 citations

Editorial

Published on 07 Apr 2022

Editorial: Mechanisms of Epigenetics and Genetics in Leukemogenesis

in Hematologic Malignancies

Yonghui Li
Fei Gao
Shujun Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.896094

2,056 views

Original Research

Published on 05 Apr 2022

The Effect of Chronic Rhinosinusitis on the Staging and Prognosis of Extranodal Natural Killer/T-Cell Lymphoma: A Single-Center Retrospective Analysis

in Hematologic Malignancies

Tingting Lei
Yu Chang
Lei Zhang
Mingzhi Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.878559

1,809 views
1 citation

Original Research

Published on 01 Apr 2022

Prognostic Impact of Platelet-Large Cell Ratio In Myelodysplastic Syndromes

in Hematologic Malignancies

Qiuni Chen
Yue Chen
Yijing Zhang
Lijuan Zhang
Kankan Chen
Zhengmei He
Chunling Wang
Liang Yu

Frontiers in Oncology

doi 10.3389/fonc.2022.846044

19,283 views
15 citations

Case Report

Published on 31 Mar 2022

Case Report: Personalized Therapeutical Approaches with Lenalidomide in Del(5q): A Case Series

in Hematologic Malignancies

Anna Stein
Anne Sophie Kubasch
Claudia Haferlach
Uwe Platzbecker

Frontiers in Oncology

doi 10.3389/fonc.2022.866470

3,220 views
2 citations

Original Research

Published on 31 Mar 2022

Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study

in Hematologic Malignancies

Moaath K. Mustafa Ali
Elizabeth M. Corley
Hanan Alharthy
Kathryn A. F. Kline
Jennie Y. Law
Seung Tae Lee
Sandrine Niyongere
Vu H. Duong
Ashkan Emadi
Maria R. Baer

Frontiers in Oncology

doi 10.3389/fonc.2022.858202

6,076 views
20 citations

Review

Published on 24 Mar 2022

Imaging for Plasma Cell Dyscrasias: What, When, and How?

in Hematologic Malignancies

Amrita Guha
Antariksh Vijan
Ujjwal Agarwal
Jayant Sastri Goda
Abhishek Mahajan
Nitin Shetty
Navin Khattry

Frontiers in Oncology

doi 10.3389/fonc.2022.825394

10,384 views
7 citations

Case Report

Published on 23 Mar 2022

Repeated Lineage Switches in an Elderly Case of Refractory B-Cell Acute Lymphoblastic Leukemia With MLL Gene Amplification: A Case Report and Literature Review

in Hematologic Malignancies

Reina Takeda
Kazuaki Yokoyama
Tomofusa Fukuyama
Toyotaka Kawamata
Mika Ito
Nozomi Yusa
Rika Kasajima
Eigo Shimizu
Nobuhiro Ohno
Kaoru Uchimaru

Frontiers in Oncology

doi 10.3389/fonc.2022.799982

5,504 views
11 citations

Review

Published on 22 Mar 2022

Biology and Treatment of Richter Transformation

in Hematologic Malignancies

Adalgisa Condoluci
Davide Rossi

Frontiers in Oncology

doi 10.3389/fonc.2022.829983

20,533 views
50 citations

Original Research

Published on 22 Mar 2022

Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience

in Hematologic Malignancies

Bruno Fattizzo
Giorgia Virginia Levati
Juri Alessandro Giannotta
Giulio Cassanello
Lilla Marcella Cro
Anna Zaninoni
Marzia Barbieri
Giorgio Alberto Croci
Nicoletta Revelli
Wilma Barcellini

Frontiers in Oncology

doi 10.3389/fonc.2022.795955

9,461 views
18 citations

Editorial

Published on 21 Mar 2022

Editorial: The Elephant in the Room: AML Relapse After Allogeneic Hematopoietic Cell Transplantation

in Hematologic Malignancies

Giorgia Battipaglia
Francesco Saraceni
Florent Malard

Frontiers in Oncology

doi 10.3389/fonc.2022.863800

1,672 views

Brief Research Report

Published on 21 Mar 2022

Point Mutations in the FLT3-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant KMT2A-PTD

in Hematologic Malignancies

Sebastian Stasik
Michael Kramer
Sven Zukunft
Christoph Röllig
Claudia D. Baldus
Uwe Platzbecker
Hubert Serve
Carsten Müller-Tidow
Kerstin Schäfer-Eckart
Martin Kaufmann

Frontiers in Oncology

doi 10.3389/fonc.2022.862991

6,109 views
4 citations

Case Report

Published on 21 Mar 2022

Case Report: Outcome and Adverse Events of Anti-PD-1 Antibody Plus Chidamide for Relapsed/Refractory Sézary Syndrome: Case Series and A Literature Review

in Hematologic Malignancies

Chao Chen
Zhaorui Liu
Jie Liu
Wei Zhang
Daobin Zhou
Yan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.842123

3,672 views
4 citations

Original Research

Published on 18 Mar 2022

Impact of IDH1 c.315C>T SNP on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study

in Hematologic Malignancies

Elizabeth M. Corley
Moaath K. Mustafa Ali
Hanan Alharthy
Kathryn A. F. Kline
Danielle Sewell
Jennie Y. Law
Seung Tae Lee
Sandrine Niyongere
Vu H. Duong
Maria R. Baer

Frontiers in Oncology

doi 10.3389/fonc.2022.804961

4,002 views
5 citations

Brief Research Report

Published on 17 Mar 2022

Physicians’ Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE Platform

in Hematologic Malignancies

Fabio Efficace
Andrea Patriarca
Mario Luppi
Leonardo Potenza
Giovanni Caocci
Agostino Tafuri
Francesca Fazio
Claudio Cartoni
Maria Teresa Petrucci
Ida Carmosino

Frontiers in Oncology

doi 10.3389/fonc.2022.826040

4,879 views
10 citations

Original Research

Published on 17 Mar 2022

Development and Validation of a Novel Prognostic Model for Overall Survival in Newly Diagnosed Multiple Myeloma Integrating Tumor Burden and Comorbidities

in Hematologic Malignancies

Shuangshuang Jia
Lei Bi
Yuping Chu
Xiao Liu
Juan Feng
Li Xu
Tao Zhang
Hongtao Gu
Lan Yang
Qingxian Bai

Frontiers in Oncology

doi 10.3389/fonc.2022.805702

4,136 views
8 citations

Original Research

Published on 17 Mar 2022

Development of a Risk Assessment Model for Early Grade ≥ 3 Infection During the First 3 Months in Patients Newly Diagnosed With Multiple Myeloma Based on a Multicenter, Real-World Analysis in China

in Hematologic Malignancies

Yufeng Shang
Weida Wang
Yuxing Liang
Natasha Mupeta Kaweme
Qian Wang
Minghui Liu
Xiaoqin Chen
Zhongjun Xia
Fuling Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.772015

3,055 views
9 citations

2,058 articles

articles

Prognostic Value of Heterogeneity Index Derived from Baseline 18F-FDG PET/CT in Mantle Cell Lymphoma

A Deep Learning Model for the Automatic Recognition of Aplastic Anemia, Myelodysplastic Syndromes, and Acute Myeloid Leukemia Based on Bone Marrow Smear

Chronic Neutrophilic Leukemia: A Comprehensive Review of Clinical Characteristics, Genetic Landscape and Management

Case Report: Castleman Disease With an Associated Stromal Spindle Cell Proliferation, PDGFRB Mutation and p53 Expression: Clonal Origins of a Rare Disease

Clonal Hematopoiesis at the Crossroads of Inflammatory Bowel Diseases and Hematological Malignancies: A Biological Link?

Diffuse Large B-Cell Lymphoma Promotes Endothelial-to-Mesenchymal Transition via WNT10A/Beta-Catenin/Snail Signaling

Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis

Leukemia Stem Cell Frequency at Diagnosis Correlates With Measurable/Minimal Residual Disease and Impacts Survival in Adult Acute Myeloid Leukemia

Editorial: Mechanisms of Epigenetics and Genetics in Leukemogenesis

The Effect of Chronic Rhinosinusitis on the Staging and Prognosis of Extranodal Natural Killer/T-Cell Lymphoma: A Single-Center Retrospective Analysis

Prognostic Impact of Platelet-Large Cell Ratio In Myelodysplastic Syndromes

Case Report: Personalized Therapeutical Approaches with Lenalidomide in Del(5q): A Case Series

Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study

Imaging for Plasma Cell Dyscrasias: What, When, and How?

Repeated Lineage Switches in an Elderly Case of Refractory B-Cell Acute Lymphoblastic Leukemia With MLL Gene Amplification: A Case Report and Literature Review

Biology and Treatment of Richter Transformation

Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience

Editorial: The Elephant in the Room: AML Relapse After Allogeneic Hematopoietic Cell Transplantation

Point Mutations in the FLT3-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant KMT2A-PTD

Case Report: Outcome and Adverse Events of Anti-PD-1 Antibody Plus Chidamide for Relapsed/Refractory Sézary Syndrome: Case Series and A Literature Review

Impact of IDH1 c.315C>T SNP on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study

Physicians’ Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE Platform

Development and Validation of a Novel Prognostic Model for Overall Survival in Newly Diagnosed Multiple Myeloma Integrating Tumor Burden and Comorbidities

Development of a Risk Assessment Model for Early Grade ≥ 3 Infection During the First 3 Months in Patients Newly Diagnosed With Multiple Myeloma Based on a Multicenter, Real-World Analysis in China